1. Home
  2. BLMN vs IRWD Comparison

BLMN vs IRWD Comparison

Compare BLMN & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$6.18

Market Cap

557.3M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.37

Market Cap

520.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
IRWD
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
557.3M
520.6M
IPO Year
2012
2010

Fundamental Metrics

Financial Performance
Metric
BLMN
IRWD
Price
$6.18
$3.37
Analyst Decision
Hold
Buy
Analyst Count
8
5
Target Price
$8.50
$5.34
AVG Volume (30 Days)
2.0M
2.3M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
7.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
$3,952,793,000.00
$338,987,000.00
Revenue This Year
$2.19
N/A
Revenue Next Year
$0.32
$4.01
P/E Ratio
$16.56
$19.03
Revenue Growth
7.72
N/A
52 Week Low
$5.90
$0.53
52 Week High
$12.97
$4.78

Technical Indicators

Market Signals
Indicator
BLMN
IRWD
Relative Strength Index (RSI) 38.50 55.41
Support Level $6.45 $3.11
Resistance Level $6.82 $3.39
Average True Range (ATR) 0.26 0.20
MACD -0.08 -0.06
Stochastic Oscillator 4.12 36.36

Price Performance

Historical Comparison
BLMN
IRWD

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: